The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zingoni, A.
Right arrow Articles by Lanier, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zingoni, A.
Right arrow Articles by Lanier, L. L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2004, 173: 3716-3724.
Copyright © 2004 by The American Association of Immunologists

Cross-Talk between Activated Human NK Cells and CD4+ T Cells via OX40-OX40 Ligand Interactions1

Alessandra Zingoni*,{dagger}, Thierry Sornasse2,{ddagger}, Benjamin G. Cocks{ddagger}, Yuetsu Tanaka§, Angela Santoni{dagger} and Lewis L. Lanier3,*

* Department of Microbiology and Immunology and the Cancer Research Institute, University of California, San Francisco, CA 94143; {dagger} Department of Experimental Medicine and Pathology, University of Rome "La Sapienza", Rome, Italy; {ddagger} Incyte Corporation, Palo Alto, CA 94304; and § Department of Immunology, Graduate School and Faculty of Medicine, University of the Ryukyus, Okinawa, Japan

It is important to understand which molecules are relevant for linking innate and adaptive immune cells. In this study, we show that OX40 ligand is selectively induced on IL-2, IL-12, or IL-15-activated human NK cells following stimulation through NKG2D, the low affinity receptor for IgG (CD16) or killer cell Ig-like receptor 2DS2. CD16-activated NK cells costimulate TCR-induced proliferation, and IFN-{gamma} produced by autologous CD4+ T cells and this process is dependent upon expression of OX40 ligand and B7 by the activated NK cells. These findings suggest a novel and unexpected link between the natural and specific immune responses, providing direct evidence for cross-talk between human CD4+ T cells and NK receptor-activated NK cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Han, Y. Fan, S. Wang, L. Jiao, H. Qiu, and X. Yang
NK Cells Contribute to Intracellular Bacterial Infection-Mediated Inhibition of Allergic Responses
J. Immunol., April 1, 2008; 180(7): 4621 - 4628.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Roy, P. F. Barnes, A. Garg, S. Wu, D. Cosman, and R. Vankayalapati
NK Cells Lyse T Regulatory Cells That Expand in Response to an Intracellular Pathogen
J. Immunol., February 1, 2008; 180(3): 1729 - 1736.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. L. Blasius, W. Barchet, M. Cella, and M. Colonna
Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells
J. Exp. Med., October 29, 2007; 204(11): 2561 - 2568.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
I. Caminschi, F. Ahmet, K. Heger, J. Brady, S. L. Nutt, D. Vremec, S. Pietersz, M. H. Lahoud, L. Schofield, D. S. Hansen, et al.
Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells
J. Exp. Med., October 29, 2007; 204(11): 2579 - 2590.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. N. Beilke and R. G. Gill
Frontiers in Nephrology: The Varied Faces of Natural Killer Cells in Transplantation Contributions to Both Allograft Immunity and Tolerance
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2262 - 2267.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Liu, S. Yu, J. Kappes, J. Wang, W. E. Grizzle, K. R. Zinn, and H.-G. Zhang
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Blood, May 15, 2007; 109(10): 4336 - 4342.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Ralainirina, A. Poli, T. Michel, L. Poos, E. Andres, F. Hentges, and J. Zimmer
Control of NK cell functions by CD4+CD25+ regulatory T cells
J. Leukoc. Biol., January 1, 2007; 81(1): 144 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Liu, L. V. Kaer, A. L. Cava, M. Price, D. I. Campagnolo, M. Collins, D. A. Young, T. L. Vollmer, and F.-D. Shi
Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease
J. Immunol., May 1, 2006; 176(9): 5247 - 5254.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Galazka, M. Stasiolek, A. Walczak, A. Jurewicz, A. Zylicz, C. F. Brosnan, C. S. Raine, and K. W. Selmaj
Brain-Derived Heat Shock Protein 70-Peptide Complexes Induce NK Cell-Dependent Tolerance to Experimental Autoimmune Encephalomyelitis
J. Immunol., February 1, 2006; 176(3): 1588 - 1599.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. R. Brooks, T. Elliott, P. Parham, and S. I. Khakoo
The Inhibitory Receptor NKG2A Determines Lysis of Vaccinia Virus-Infected Autologous Targets by NK Cells
J. Immunol., January 15, 2006; 176(2): 1141 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Stewart, F. Laugier-Anfossi, F. Vely, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagne, G. Ferracci, F. A. Arosa, et al.
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors
PNAS, September 13, 2005; 102(37): 13224 - 13229.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Uehara, C. M. Chase, W. H. Kitchens, H. S. Rose, R. B. Colvin, P. S. Russell, and J. C. Madsen
NK Cells Can Trigger Allograft Vasculopathy: The Role of Hybrid Resistance in Solid Organ Allografts
J. Immunol., September 1, 2005; 175(5): 3424 - 3430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. S. Warren, A. L. Jones, C. Freeman, J. Bettadapura, and C. R. Parish
Evidence That the Cellular Ligand for the Human NK Cell Activation Receptor NKp30 Is Not a Heparan Sulfate Glycosaminoglycan
J. Immunol., July 1, 2005; 175(1): 207 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. P. Trivedi, P. C. Roberts, N. A. Wolf, and R. H. Swanborg
NK Cells Inhibit T Cell Proliferation via p21-Mediated Cell Cycle Arrest
J. Immunol., April 15, 2005; 174(8): 4590 - 4597.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.